RNase 3 (1-36)[P3,Q4,L18,N19,P20,C23DEL], RN3(5-17P22-36)

General Information


DRACP ID  DRACP01999

Peptide Name   RNase 3 (1-36)[P3,Q4,L18,N19,P20,C23DEL], RN3(5-17P22-36)

Sequence  RPFTRAQWFAIQHISPRTIAMRAINNYRWR

Sequence Length  30

UniProt ID  P12724 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
Hep-G2 Hepatoblastoma Blastoma IC50=74.43±1.91 µM MTT assay 4 h 1

Hemolytic Activity  Sheep erythrocytes: 50% Hemolysis=178.33±81.72 µM; Horse erythrocytes: 44±4% Hemolysis=250 µM

Normal (non-cancerous) Cytotoxicity  MRC-5: IC50>150 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01999

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C171H262N56O39S

Absent amino acids  CDEGKLV

Common amino acids  R

Mass  427581

Pl  12.8

Basic residues  7

Acidic residues  0

Hydrophobic residues  12

Net charge  7

Boman Index  -8733

Hydrophobicity  -66.67

Aliphatic Index  65.33

Half Life 
  Mammalian: 0.8 hour
  Yeast: 10 min
  E.coli: >10 hour

Extinction Coefficient cystines  12490

Absorbance 280nm  430.69

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29763807

Title  Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides

Doi 10.1016/j.ejmech.2018.05.012

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_14140

DRACP is developed by Dr.Zheng's team.